The application of RTE markers for the diagnosis of thymoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054165

Enrollment

Unknown

Registered

2021-12-10

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymoma

Interventions

Gold Standard:Histopathology

Index test:Flow&#32

cytometry,&#32

interleukin&#32

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Adult, > 20 years old; 2. Patients with thymic space occupying lesions on imaging (chest CT or MRI); 3. The patients voluntarily participated in the study, signed the consent form, had good compliance, obeyed the follow-up, and were willing and able to abide by the protocol during the study.

Exclusion criteria

Exclusion criteria: No biopsy or surgery, no histopathological diagnosis.

Design outcomes

Primary

Measure	Time frame
Interleukin 8;	—

Countries

China

Contacts

Public ContactDing Jianyong

Zhongshan Hospital Affiliated to Fudan University

ding.jianyong@zs-hospital.sh.cn+86 13681975591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026